NOBEX Receives Two Patents for PEG-Based Polymers

NOBEX has been issued two patents for its polyethylene glycol (PEG) and "microalkylPEGylation" technology.

The company plans to use the technology to convert injectable only drugs into oral form and is currently working with partner Biocon to develop an oral insulin product.